CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-05 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +21,775 | $8.02 | $175K | 29,004 |
| 2025-11-05 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −21,775 | $134.49 | $2.9M | 7,229 |
| 2025-11-05 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,775 | 251,797 | ||
| 2025-11-04 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +50,459 | $8.02 | $405K | 57,688 |
| 2025-11-04 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −50,459 | $133.79 | $6.8M | 7,229 |
| 2025-11-04 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,459 | 273,572 | ||
| 2025-11-03 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +91,705 | $8.02 | $735K | 98,934 |
| 2025-11-03 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −91,705 | $132.34 | $12.1M | 7,229 |
| 2025-11-03 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −91,705 | 324,031 | ||
| 2025-10-08 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +12,774 | $8.02 | $102K | 20,003 |
| 2025-10-08 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −12,774 | $118.84 | $1.5M | 7,229 |
| 2025-10-08 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,774 | 415,736 | ||
| 2025-10-07 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +13,390 | $8.02 | $107K | 20,619 |
| 2025-10-07 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −13,390 | $118.77 | $1.6M | 7,229 |
| 2025-10-07 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,390 | 428,510 | ||
| 2025-10-06 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +19,220 | $8.02 | $154K | 26,449 |
| 2025-10-06 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −19,220 | $120.17 | $2.3M | 7,229 |
| 2025-10-06 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,220 | 441,900 | ||
| 2025-09-22 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $2.85 | $29K | 10,000 |
| 2025-09-22 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −10,000 | $115.96 | $1.2M | 0 |
Page 6 of 22 · 422 trades